The pharma industry’s focus is shifting from the transactional approach to a transformational approach by partnering with patients for clinical trial development and beyond. Pharma is doing this to be able to always reflect real-world patient experiences accurately or address what is most important to a patient. This is important because today’s patients have access to more scientific information, are better informed about their conditions, and are more vocal about their desire for inclusion in all aspects of the life cycle of a medicine. So, pharma has a unique opportunity to help define what success in this context looks like, and medical affairs is a vital additional partner in this equation, bridging the gap between pharma and patients.
From Transactional to Transformational Bringing Patient Centricity to the Next level
Why should you download this whitepaper?
This whitepaper by Cactus Life Sciences sheds light on the following aspects of the patient involvement journey:
- Dealing with obstacles such as low health literacy and the proliferation of misinformation due to an explosion of broadcast and social media content
- Identifying the power of close collaboration between medical affairs, patient advocacy groups, patient experts, and influencers to overcome these obstacles
- Understanding the role of medical affairs in this transformational process
- Creating the right approach through integration, involvement, and building trust in order to build a patient pillar